US FDA cautions against California plant making compounded weight-loss drugs
The U.S. Food and Drug Administration on Friday warned against the use of compounded drugs, including versions of popular weight-loss products made at a California facility, over concerns they could be contaminated.
POPULAR POSTS
Wall Street awaits Amgen’s weight-loss drug data
November 22, 2024
Neuralink receives Canadian approval for brain chip trial
November 22, 2024
Bitcoin advances towards $100,000
November 22, 2024
China’s Baidu posts 3% drop in third-quarter revenue
November 22, 2024
LIVE STREAM